Balancing basic, genetic enhancement and cultivar development research in an evolving US plant germplasm system

Abstract

The structure of the United States (U.S.) public-private plant genetic research system is being transformed by the emergence of practical biotechnology protocols for creating transgenic plants; and by strengthened intellectual property protection in plants. This paper draws on some simple principles of incentives and appropriability to discuss the sharing of research responsibilities between the public and private sectors.